Related Experiment Videos

Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor

L Quintanilla-Martinez1, C Thieblemont, F Fend

  • 1Hematopathology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

Insights

Mantle cell lymphomas (MCL) show a unique lack of correlation between p27Kip1 expression and cell proliferation, unlike other lymphomas. This uncoupling may drive MCL pathogenesis.

Area of Science:

  • Cell Biology
  • Oncology
  • Molecular Biology

Background:

  • p27Kip1 is a cyclin-dependent kinase inhibitor regulating cell cycle entry.
  • Cyclin-dependent kinase inhibitors are implicated as tumor suppressors in various cancers.
  • p27Kip1 levels influence cell cycle progression by interacting with cyclin complexes.

Purpose of the Study:

  • To investigate p27Kip1 expression in non-Hodgkin's lymphomas, particularly mantle cell lymphoma (MCL).
  • To correlate p27Kip1 expression with proliferation markers (Ki67) and p53 in MCL.
  • To analyze p27Kip1 gene structure in MCL.

Main Methods:

  • Examined p27Kip1 expression in 116 non-Hodgkin's lymphomas, including 50 MCL cases.
  • Correlated p27Kip1 with Ki67 (proliferation) and p53 expression.
  • Analyzed p27Kip1 gene structure by Southern blot in MCL.

Main Results:

  • p27Kip1 inversely correlated with Ki67 in lymphomas, except MCL.
  • Typical MCL showed negative p27Kip1 in 88% of cases, regardless of proliferation.
  • Blastic MCL variant showed p27Kip1 expression in 80% despite high proliferation.
  • p53 expression was higher in blastic MCL (70%) than typical MCL (20%).
  • No p27Kip1 gene deletions were found.

Conclusions:

  • MCL exhibits a distinct uncoupling of p27Kip1 expression from proliferation rate.
  • This phenomenon may be linked to high cyclin D1 levels in MCL.
  • The dysregulation of p27Kip1 likely contributes to MCL pathogenesis and cell cycle control.

Related Concept Videos